CRISPR THERAPEUTICS LTD earnings per share and revenue

1CG earnings per share for the last quarter are -0.91 EUR whereas the estimation was -1.24 EUR which accounts for 27.06% surprise. Company revenue for the same period amounts to 540.68 k EUR despite the estimated figure of 5.90 M EUR. Estimated earnings per share for the next quarter are -1.20 EUR, and revenue is expected to reach 7.83 M EUR. Also watch annual changes over time to get a bigger picture of 1CG earnings per share and revenue dynamics.